Join the club for FREE to access the whole archive and other member benefits.

Viet Ly

Co-founder and CFO at YouthBio Therapeutics and General Partner/ Fund Manager at Inception Capital

Viet is an angel investor and entrepreneur with over twenty years of fund management, trading, equities analysis, market forecasting, and business development experience. He is a recipient of the 2016 Wealth & Finance International U.S. Venture Capital Fund Manager of the Year Award.

Viet has researched and invested in biotech companies since 2004 and helped build and presently serves as a strategic adviser to Genprex, a gene therapy biotech company. He has also been an early investor in Airbnb, SpaceX, and Virgin Hyperloop.

Viet is passionate about the global markets, building businesses, emerging technology and cancer biotech.

Visit website: https://youthbiotx.com/#viet

 vietinception

 vietgenprex

See also: Company YouthBio Therapeutics - Developing rejuvenation gene therapies based on partial reprogramming by Yamanaka factors

Details last updated 15-Apr-2022

Viet Ly is also referenced in the following:

YouthBio Therapeutics

Developing rejuvenation gene therapies based on partial reprogramming by Yamanaka factors

Viet Ly News

YouthBio Therapeutics unveils its board, with João Pedro de Magalhães as CSO

YouthBio Therapeutics unveils its board, with João Pedro de Magalhães as CSO

CISION PR Newswire - 14-Apr-2022

Another company enters the cellular reprogramming race - hopefully at least one will cross the finishing line